Apply to join the 2025 Fralin Commercialization Fellows Program
Applications are due before 5 p.m. on Tuesday, March 4, 2025
January 7, 2025
Applications for the Fralin Health Sciences and Technology Commercialization Fellows Program are now open. Doctoral candidates, postdoctoral researchers, and research assistants/associates from across Virginia Tech who conduct health sciences and technology-related research are eligible to apply.
The program, in its 8th year, is closely linked with the Roanoke based RAMP (Regional Acceleration and Mentoring Program) program for high-potential start-ups. Fellows will participate in the same Boot Camp program as individuals from RAMP cohort companies. Up to 5 Fellows are accepted each year. The Fellows program pays for the Fellows to participate in the Bootcamp. A new feature of the 2025 Fellows program is that the PI of an accepted Fellow will receive $5,000 for early-stage research related to a commercialization idea.
The program runs annually from March through October and Fellows are expected to contribute no more than four hours per week to the program, with the exception of Boot Camp training in late March/early April. Most of the program takes place on Zoom, so selected Fellows can participate from anywhere.
By the end of the program, Fellows demonstrate their knowledge by identifying a commercial idea, researching it with the support of a mentor, and pitching preliminary findings about the idea’s value proposition and market potential to a panel of entrepreneurs. The selection committee prefers applicants whose PI has a research-related commercial idea.
How to Apply:
- To learn more about the Fellows Program, register to attend a virtual information session with former participants from noon to 1 p.m. on Wednesday, February 5, 2025.
- Before applying, talk to your supervisor to ensure that they agree to your participation in the fellowship program, and please note their approval on your application.
- Complete your application online before 5 p.m. on Tuesday, March 4, 2025.
If you have any questions, please contact Hal Irvin.